Affimed NV (AFMD)
3.65
-0.08
(-2.28%)
USD |
NASDAQ |
Nov 14, 16:00
3.65
0.00 (0.00%)
After-Hours: 20:00
Affimed Enterprise Value: 30.82M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 30.82M |
| November 12, 2024 | 31.21M |
| November 11, 2024 | 32.15M |
| November 08, 2024 | 32.62M |
| November 07, 2024 | 32.31M |
| November 06, 2024 | 28.23M |
| November 05, 2024 | 29.64M |
| November 04, 2024 | 23.53M |
| November 01, 2024 | 23.37M |
| October 31, 2024 | 22.90M |
| October 30, 2024 | 24.62M |
| October 29, 2024 | 24.78M |
| October 28, 2024 | 25.09M |
| October 25, 2024 | 24.39M |
| October 24, 2024 | 24.31M |
| October 23, 2024 | 25.41M |
| October 22, 2024 | 26.82M |
| October 21, 2024 | 25.56M |
| October 18, 2024 | 27.92M |
| October 17, 2024 | 24.15M |
| October 16, 2024 | 24.47M |
| October 15, 2024 | 21.25M |
| October 14, 2024 | 21.17M |
| October 11, 2024 | 19.29M |
| October 10, 2024 | 19.14M |
| Date | Value |
|---|---|
| October 09, 2024 | 20.86M |
| October 08, 2024 | 21.49M |
| October 07, 2024 | 21.80M |
| October 04, 2024 | 22.58M |
| October 03, 2024 | 23.37M |
| October 02, 2024 | 23.84M |
| October 01, 2024 | 24.15M |
| September 30, 2024 | 24.94M |
| September 27, 2024 | 24.94M |
| September 26, 2024 | 24.00M |
| September 25, 2024 | 24.15M |
| September 24, 2024 | 25.41M |
| September 23, 2024 | 25.56M |
| September 20, 2024 | 30.11M |
| September 19, 2024 | 34.35M |
| September 18, 2024 | 35.29M |
| September 17, 2024 | 36.07M |
| September 16, 2024 | 34.66M |
| September 13, 2024 | 34.97M |
| September 12, 2024 | 32.93M |
| September 11, 2024 | 32.62M |
| September 10, 2024 | 33.25M |
| September 09, 2024 | 33.72M |
| September 06, 2024 | 31.21M |
| September 05, 2024 | 31.68M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-86.47M
Minimum
Mar 24 2023
1.086B
Maximum
Apr 28 2021
204.46M
Average
104.91M
Median
Enterprise Value Benchmarks
| InflaRx NV | 20.31M |
| BioNTech SE | 8.336B |
| Immatics NV | 314.32M |
| CureVac NV | 394.66M |
| ATAI Life Sciences NV | 157.38M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.64M |
| Revenue (Quarterly) | 0.1658M |
| Total Expenses (Quarterly) | 16.97M |
| EPS Diluted (Quarterly) | -1.088 |
| Profit Margin (Quarterly) | -10.03K% |
| Earnings Yield | -156.3% |
| Normalized Earnings Yield | -160.93 |